Helen Sabzevari - 17 Jul 2021 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role
President and CEO, Director
Signature
/s/ Helen Sabzevari, by Donald P. Lehr, as attorney-in-fact
Issuer symbol
PGEN
Transactions as of
17 Jul 2021
Net transactions value
-$68,047
Form type
4
Filing time
20 Jul 2021, 18:11:00 UTC
Previous filing
28 Jun 2021
Next filing
04 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGEN Common Stock Options Exercise +25,000 +3.5% 730,057 17 Jul 2021 Direct F1
transaction PGEN Common Stock Sale $68,047 -12,531 -1.7% $5.43 717,526 19 Jul 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGEN Restricted Stock Units Options Exercise $0 -25,000 -100% $0.000000* 0 17 Jul 2021 Common Stock 25,000 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock.
F2 This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs.
F3 The RSUs were granted on March 28, 2018 and have vested in full.